MedPath

Comparison of Two Daily Disposable Soft Contact Lenses

Not Applicable
Completed
Conditions
Astigmatism Bilateral
Interventions
Device: midafilcon A
Device: somofilcon A
Registration Number
NCT03779503
Lead Sponsor
Coopervision, Inc.
Brief Summary

The aim of this study was to investigate the short-term clinical performance and subjective acceptance of the two study lenses.

Detailed Description

This study was a randomised, double-masked, crossover, bilateral dispensing study, controlled by cross-comparison. Fifty-five subjects will wear each lens brand for approximately one week in random order. Lenses were worn on a daily wear, daily disposable basis.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
55
Inclusion Criteria
  1. They are between 18 and 40 years of age (inclusive).
  2. They understand their rights as a research subject and are willing to sign a Statement of Informed Consent.
  3. They are willing and able to follow the protocol.
  4. They are an existing silicone hydrogel reusable spherical contact lens wearer in both eyes.
  5. They have a contact lens spherical prescription between -0.25D and -6.00D (inclusive) based on ocular refraction.
  6. They own a wearable pair of spectacles and wear them on the day of the initial visit.
  7. At dispensing, they can attain at least 0.20 logMAR distance high contrast visual acuity in each eye with the study lenses within the available power range.
  8. They are willing to comply with the wear schedule (at least five days per week and for at least eight hours per day).
  9. They agree not to participate in other clinical research for the duration of the study.
Exclusion Criteria
  1. They have an ocular disorder, which would normally contra-indicate contact lens wear.
  2. They have a systemic disorder, which would normally contra-indicate contact lens wear.
  3. They are using any topical medication such as eye drops or ointment, or use any rewetting/lubricating drops whilst on this study.
  4. They are aphakic.
  5. They have had corneal refractive surgery.
  6. They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.
  7. They are pregnant or breastfeeding.
  8. They have any ocular abnormality which would, in the opinion of the investigator, normally contraindicate contact lens wear
  9. They have any infectious disease which would, in the opinion of the investigator, contraindicate contact lens wear or pose a risk to study personnel; or they have any immunosuppressive disease (e.g. HIV), or a history of anaphylaxis or severe allergic reaction.
  10. They have taken part in any contact lens or care system clinical research within two weeks prior to starting this study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
midafilcon Amidafilcon ASubjects will be randomized to wear midafilcon A 1 day for one week of daily wear during the study.
somofilcon Asomofilcon ASubjects will be randomized to wear somofilcon A 1 day for one week of daily wear during the study.
Primary Outcome Measures
NameTimeMethod
Lens Fit - Corneal CoverageOne Week

Assessment of corneal coverage of lens (extremely inadequate, slightly inadequate, optimum, slightly excessive, extremely excessive)

Lens Fit - Lens MovementOne Week

Lens movement assessed per corneal coverage (extremely inadequate, slightly inadequate, optimum, slightly excessive, extremely excessive)

Lens Fit - Horizontal CentrationOne Week

Assessment of horizontal centration of lens (extremely nasal, slightly nasal, optimum, slightly temporal, extremely temporal)

Lens Fit - Vertical CentrationOne Week

Assessment of vertical centration of lens (extremely inferior, slightly inferior, optimum, slightly superior, extremely superior)

Secondary Outcome Measures
NameTimeMethod
Subjective Score for VisionOne week

Subjects will score on visual analogue scale for Vision (0 -100) (0 - Unacceptable, 20 - Very poor, 40 - Poor, 60 - Good, 80 - Very Good, 100 - Excellent)

Trial Locations

Locations (1)

CooperVision Inc.

🇺🇸

Pleasanton, California, United States

© Copyright 2025. All Rights Reserved by MedPath